Biomerica (BMRA) News Today $3.43 +0.01 (+0.29%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$3.35 -0.08 (-2.36%) As of 07:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BMRA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of GastroenterologyJune 7, 2025 | seekingalpha.comBiomerica Appoints Eric B. Chin to Board of Directors and Audit Committee ChairJune 6, 2025 | globenewswire.comBiomerica (NASDAQ:BMRA) Shares Pass Below 200 Day Moving Average - Here's What HappenedJune 6, 2025 | americanbankingnews.comBiomerica's inFoods® IBS Clinical Study Results Published in June Issue of GastroenterologyJune 5, 2025 | globenewswire.comBiomerica's inFoods® IBS Demonstrates Significant Reductions in GI Pain and Bloating in Real-World StudyMay 24, 2025 | nasdaq.comBiomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback SystemMay 22, 2025 | globenewswire.comBiomerica Submits PLA Code Application to Enhance Patient Access to inFoods® IBS Diagnostic TestMay 9, 2025 | nasdaq.comPLA Code Application Filed for inFoods IBS Test - A Key Step Toward ReimbursementMay 7, 2025 | tmcnet.comPLA Code Application Filed for inFoods IBS Test — A Key Step Toward ReimbursementMay 7, 2025 | globenewswire.comBiomerica announces Fortel Ulcer Test approved for sale by UAE MinistryApril 24, 2025 | markets.businessinsider.comUnited Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori InfectionApril 23, 2025 | globenewswire.comBiomerica Third Quarter 2025 Earnings: US$0.061 loss per share (vs US$0.11 loss in 3Q 2024)April 18, 2025 | finance.yahoo.comBiomerica Announced 1-for-8 Reverse Stock SplitApril 18, 2025 | nasdaq.comBiomerica, Inc.: Biomerica Announces Reverse Stock SplitApril 18, 2025 | finanznachrichten.deBiomerica Inc trading halted, news pendingApril 18, 2025 | markets.businessinsider.comBiomerica says UAE Ministry of Health approves Fortel Kidney Disease TestApril 18, 2025 | markets.businessinsider.comUnited Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney DamageApril 17, 2025 | markets.businessinsider.comUnited Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney DamageApril 17, 2025 | globenewswire.comBiomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s DisappointedApril 16, 2025 | msn.comBiomerica, Inc.: Biomerica Reports Third Quarter Fiscal 2025 Financial ResultsApril 16, 2025 | finanznachrichten.deBiomerica reports Q3 EPS ($1.20) vs ($1.90) last yearApril 16, 2025 | markets.businessinsider.comBiomerica Announces Reverse Stock SplitApril 16, 2025 | globenewswire.comBiomerica Reports Third Quarter Fiscal 2025 Financial ResultsApril 15, 2025 | markets.businessinsider.comBiomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative ColitisFebruary 26, 2025 | markets.businessinsider.comBiomerica achieves IVDR certification in European unionFebruary 26, 2025 | msn.comBiomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative ColitisFebruary 26, 2025 | globenewswire.comBiomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical JournalFebruary 19, 2025 | globenewswire.comUnited Arab Emirates MOHAP approves Biomerica’s Fortel PSA Screening TestJanuary 16, 2025 | markets.businessinsider.comBiomerica's rapid PSA test gains UAE approvalJanuary 16, 2025 | msn.comUnited Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate CancerJanuary 16, 2025 | globenewswire.comBiomerica Second Quarter 2025 Earnings: US$0.055 loss per share (vs US$0.09 loss in 2Q 2024)January 16, 2025 | finance.yahoo.comBiomerica reports Q2 EPS (6c) vs. (9c) last yearJanuary 16, 2025 | msn.comBiomerica Posts $1.64 Mln In Q2 Revenue, Marks 5% Year-over-Year GrowthJanuary 16, 2025 | markets.businessinsider.comBiomerica Reports Second Quarter Fiscal 2025 Financial ResultsJanuary 15, 2025 | globenewswire.comBiomerica secures three key international patents for inFoods TechnologyNovember 22, 2024 | markets.businessinsider.comBiomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative ColitisNovember 21, 2024 | markets.businessinsider.comBiomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative ColitisNovember 21, 2024 | globenewswire.comBiomerica granted additional 180-day period to meet listing complianceNovember 8, 2024 | markets.businessinsider.comNasdaq grants Biomerica an additional 180 days to meet listing compliance requirementsNovember 7, 2024 | globenewswire.comBiomerica Gains on IBS AnnouncementOctober 30, 2024 | baystreet.caBiomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal PainOctober 30, 2024 | globenewswire.comBiomerica Reports First Quarter Fiscal 2025 Financial ResultsOctober 16, 2024 | globenewswire.comThe Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate CancerSeptember 4, 2024 | globenewswire.comBiomerica, Inc.: Biomerica Reports Fiscal 2024 Year End ResultsAugust 29, 2024 | finanznachrichten.deBiomerica Reports Fiscal 2024 Year End ResultsAugust 29, 2024 | globenewswire.comBiomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS SufferersJuly 1, 2024 | globenewswire.comBiomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024May 13, 2024 | globenewswire.comBiomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution AgreementApril 29, 2024 | globenewswire.comBiomerica expands offices, secures new patentsApril 16, 2024 | investing.comBiomerica provides update on inFoods® IBS expansionApril 15, 2024 | globenewswire.com Get Biomerica News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter. Email Address BMRA Media Mentions By Week BMRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRA News Sentiment▼0.931.01▲Average Medical News Sentiment BMRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRA Articles This Week▼50▲BMRA Articles Average Week Get Biomerica News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LAVA Therapeutics News SCYNEXIS News Tempest Therapeutics News Kezar Life Sciences News FibroGen News Rani Therapeutics News Grace Therapeutics News ALX Oncology News Pulmatrix News Coeptis Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRA) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomerica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomerica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
